Videos / Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD
In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).
Detection, Assessment and Management of Pulmonary Fibrosis
Practical Melanoma Management for GPs
Preventing Renal Failure in Type 2 Diabetes – New Options
Management of Post-Vaccination Reactions
expert
Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals